Related Experiment Videos
Tissue distribution and kininogen gene expression after acute-phase inflammation
1Department of Pharmacology, Medical University of South Carolina, Charleston 29425.
Biochimica Et Biophysica Acta
|March 17, 1988
Summary
A new monoclonal antibody targets kininogens, crucial proteins in inflammation. This antibody helps researchers study kininogen distribution and regulation during inflammatory responses, particularly in the liver.
Area of Science:
- Immunology
- Biochemistry
- Molecular Biology
Background:
- Kininogens are precursors to bradykinin, a key mediator of inflammation and blood pressure regulation.
- Understanding kininogen expression and localization is vital for studying inflammatory diseases.
Purpose of the Study:
- To develop and characterize a specific monoclonal antibody targeting kininogens.
- To investigate the distribution and regulation of kininogens during acute inflammation.
Main Methods:
- Hybridoma technology for monoclonal antibody production.
- Enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA) for antibody screening.
- Western blotting and immunohistochemistry for kininogen localization and detection.
- Northern and dot blot analyses for mRNA expression studies.
Main Results:
- A novel monoclonal antibody (IgG1) was successfully generated, recognizing bradykinin, Lys-bradykinin, Met-Lys-bradykinin, and various kininogens.
- Kininogen levels significantly increased in rat liver, serum, and multiple organs during turpentine-induced inflammation.
- Immunohistochemistry revealed kininogen localization in liver parenchymal cells, submandibular gland, and kidney tubules.
- Kininogen mRNA levels were upregulated specifically in the liver following inflammation.
Conclusions:
- The developed monoclonal antibody is a valuable tool for kininogen research.
- Rat kininogens are widely distributed but primarily induced in the liver during acute inflammation.
- This study provides insights into the role of kininogens in inflammatory processes.